SCHEMBL17097341

SCHEMBL17097341

CO[C@@H]1O[C@H](CO)[C@@H](OC2O[C@H](CO)[C@H](O)[C@H](NC(=O)c3ccccc3C(=O)O)[C@H]2O)[C@H](O)[C@H]1NC(C)=O

nearest known ligand 0.84

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 10/20 0.84
▸ LGALS7; LGALS7B P47929 4/20 0.79
▸ LGALS1 P09382 2/20 0.79
▸ LGALS9 O00182 4/20 0.57
▸ LGALS8 O00214 1/20 0.47
▸ LGALS4 P56470 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA9 Q16790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5354309 1.00 LGALS3 (0.84) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL5354301 1.00 LGALS3 (0.84) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL17681092 0.91 LGALS3 (1.00) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL19976166 0.91 LGALS3 (1.00) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL5356738 0.91 LGALS3 (0.82) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL5356735 0.91 LGALS3 (0.82) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL5351236 0.86 LGALS3 (0.71) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL5351233 0.86 LGALS3 (0.71) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL19976179 0.85 LGALS3 (0.79) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL17681096 0.85 LGALS3 (0.79) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9770503-B2 Immunomodulating compositions and uses therefor CANCURE LIMITED ACN 164 438 359 (AU) 2017-09-26 — — US disclosed
US-20150265701-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR CANCURE LIMITED ACN 164 438 359 (AU) 2015-09-24 — — US disclosed
Send feedback